Are there prospective studies that, in fact, are designed to evaluate the effects of currently approved chaperone- and ERT-based treatments for FD on the progression of CV complications of FD?

Are there prospective studies that, in fact, are designed to evaluate the effects of currently approved chaperone- and ERT-based treatments for FD on the progression of CV complications of FD?

CLICK HERE FOR CME CREDIT

Are there prospective studies that, in fact, are designed to evaluate the effects of currently approved chaperone- and ERT-based treatments for FD on the progression of CV complications of FD? 

Created by

CMEducation Resources IQ&A Fabry Disease Diagnostic Intelligence Zone

Presenter

John Jefferies, MD

John Jefferies, MD

Jay M. Sullivan Endowed Chair in Cardiovascular Medicine
Chief of Cardiology
University of Tennessee Health Science Center (UTHSC)
Co-Director, UT Methodist Institute for Cardiovascular Science
University of Tennessee Heart Institute
Memphis, TN